Filing Details

Accession Number:
0000898432-19-001057
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-02 19:06:52
Reporting Period:
2019-08-01
Accepted Time:
2019-08-02 19:06:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325618 Iradimed Corp IRMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1254747 Brent Johnson C/O Iradimed Corporation
1025 Willa Springs Dr.
Winter Springs FL 32708
Exec. Vp Of Ww Sales And Mktg No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-01 2,000 $0.93 3,368 No 4 A Direct
Common Stock Disposition 2019-08-01 2,000 $23.51 1,368 No 4 S Direct
Common Stock Acquisiton 2019-08-02 3,000 $0.93 4,368 No 4 A Direct
Common Stock Disposition 2019-08-02 3,000 $22.37 1,368 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-08-01 2,000 $0.00 2,000 $0.93
Common Stock Stock Option (Right to Buy) Disposition 2019-08-02 3,000 $0.00 3,000 $0.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
191,775 2021-12-27 No 4 M Direct
188,775 2021-12-27 No 4 M Direct
Footnotes
  1. The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019.
  2. This transaction was executed in multiple trades at prices ranging from $21.97 to $22.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.